OceansBio co.,ltd. (XKON:332190)

OceansBio co.,ltd. Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Financial Efficiency

Fiscal Year	Current	FY 2023	FY 2022
Period Ending	Jul 29, 2026	Dec 31, 2023	Dec 31, 2022
Debt / Equity Ratio	-2.74	-2.74	3.26
Net Debt / Equity Ratio	-1.35	-1.35	0.11
Net Debt / EBITDA Ratio	-0.27	-0.27	-0.03
Net Debt / FCF Ratio	-0.57	-0.57	-0.05
Asset Turnover	0.12	0.12	-
Quick Ratio	0.56	0.56	1.11
Current Ratio	0.69	0.69	1.16
Return on Assets (ROA)	-111.96%	-111.96%	-
Return on Capital Employed (ROCE)	30463.70%	30463.70%	-225.80%

Yields

Fiscal Year	Current	FY 2023	FY 2022
Period Ending	Jul 29, 2026	Dec 31, 2023	Dec 31, 2022
Buyback Yield / Dilution	-	0.01%	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2023

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every year for this company.

Update frequency:

Yearly

Last checked:

Jul 30, 2026

Data Sources Report a data error